M&A
confidence high
sentiment neutral
materiality 0.75
Quanome to issue 6,541,236 shares for about 5% stake in QAI Labs
Lakeside Holding Ltd
- Quanome Technologies signed a Nov. 4, 2026 stock purchase agreement to acquire 31,579 newly issued QAI Labs shares for 6,541,236 QNME common shares.
- The QNME shares equal about 19% of pre-issuance outstanding stock and 15.97% after issuance; the QAI Labs stake is about 5%.
- Closing is subject to regulatory consents, no material adverse change, and a Dec. 31, 2026 outside date, with termination rights.
- The parties assigned the consideration shares a $5.0 million value, implying a ~$100 million QAI Labs equity valuation; QAI Labs is pre-commercial.
- QAI Labs is developing NOVA-3, an AI-enabled multi-specific antibody discovery platform combining quantum algorithms on classical simulators with lab testing.